Anika Therapeutics, Inc. - ANIK

About Gravity Analytica
Recent News
- 02.12.2026 - Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
- 11.12.2025 - End-of-Year Health Check: Planning for a Strong Start to 2026
- 11.05.2025 - Anika Reports Third Quarter 2025 Financial Results
- 10.23.2025 - Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
- 10.06.2025 - Reimagining Achilles Tendon Repair with the Integrity Implant
- 09.05.2025 - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- 08.27.2025 - Why Choosing a Non-Xenograft Implant Matters
- 07.30.2025 - Anika Reports Second Quarter 2025 Financial Results
Recent Filings
- 02.03.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.27.2026 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
- 01.08.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 01.08.2026 - EX-99.1 EX-99.1
- 01.08.2026 - 8-K Current report
- 11.21.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
- 11.07.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 11.05.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 11.05.2025 - 8-K Current report
- 11.05.2025 - S-8 Securities to be offered to employees in employee benefit plans